Dermatology has been disparaged by other specialties as devoid of efficacious treatments beyond topical steroids. But increasingly, one of the major growth areas in the field is new therapeutics.
Primary cutaneous T-cell lymphomas represent a wide variety of non-Hodgkin lymphomas that are characterized by a distinct clinical presentation. Advanced molecular and biological techniques have enhanced the recognition of cutaneous T-cell lymphomas.
PRIMARY CUTANEOUS T-cell lymphomas (CTCL) represent a heterogeneous group of lymphomas with a distinct clinical presentation, behaviour, and prognosis.
Actinic keratosis is currently believed to be an early stage in the evolution of squamous cell carcinoma.
SCIENTISTS have speculated that the replication of malignant cells and invasion of surrounding tissue represents a failure of the immune system, which is constantly eliminating malignant cells.
In this article the etiology, pathogenesis and treatment options for squamous cell carcinoma in the organ transplant recipient (OTR) are discussed.